The efficacy and safety of degarelix: a 12-month,...

BJU International 2008 Vol. 102; Iss. 11

The efficacy and safety of degarelix: a 12-month, comparative, randomized, open-label, parallel-group phase III study in patients with prostate cancer

Laurence Klotz, Laurent Boccon-Gibod, Neal D. Shore, Cal Andreou, Bo-Eric Persson, Per Cantor, Jens-Kristian Jensen, Tine Kold Olesen, Fritz H. Schröder
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
102
Year:
2008
Language:
english
Pages:
8
DOI:
10.1111/j.1464-410x.2008.08183.x
File:
PDF, 305 KB
english, 2008
Conversion to is in progress
Conversion to is failed